|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Metastases | |||||
| Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Neoplasm Metastasis | |||||
| 3 | More general conditions related to this trial | ||||
| Neoplasms | |||||
| Neoplastic Processes | |||||
| Pathologic Processes | |||||
| 4 | Interventions listed in this trial | ||||
| ALIMTA | |||||
| folic acid | |||||
| multi-vitamins | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Pemetrexed | |||||
| 6 | More general drug interventions related to this trial | ||||
| Antimetabolites | |||||
| Antimetabolites, Antineoplastic | |||||
| Antineoplastic Agents | |||||
| Enzyme Inhibitors | |||||
| Folic Acid Antagonists | |||||
| Growth Substances | |||||
| Hematinics | |||||
| Hematologic Agents | |||||
| Micronutrients | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| Vitamin B Complex | |||||
| Vitamins | |||||
| 7 | Sponsors listed in this trial | ||||
| Eli Lilly and Company | |||||